Alliance Pharma – half year trading update encourages, still a buy

Published 30 days ago

Alliance Pharma (APH) has updated on trading for the first half of 2017, ahead of a results announcement expected on 13th September…

Alliance Pharma – positive AGM update, remains a buy

Published 83 days ago

Alliance Pharma (APH) has made an AGM update announcement, including that trading “is good and in line with the board's expectations” and that “cash flow in the business remains strong”. This is a healthy reaffirmation of our BUY tip of last month which is now well in the money.

Alliance Pharma - once again a buy

Published 121 days ago

Specialty pharmaceutical company, Alliance Pharma (APH) is a previous successful share tip for us - recommended at 31p, with gains banked at 43p in 2015. However, there has since been positive development which looks inadequately reflected in a current sub 50p offer price and, noting also the continued presence of famed investors Nigel Wray and Slater Investments as major shareholders…

Video: John Dawson, CEO of Alliance Pharma, speaks at UK Investor Show 2017

Published 126 days ago

In this video from the storming success that was the 2017 UK Investor Show, John Dawson, CEO of Alliance Pharma (APH), is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

Lucy Wray: UK Investor ticket update just 400 of 3000 left for April 1 - grab your free one NOW

Published 158 days ago

Time really is running out if you want to attend what is the country's biggest and most exciting one day event for those who are serious about making money from shares. UK Investor Show will be having a 15th birthday party on April 1 (no kidding) in Westminster, London. But as of today fewer than 400 of the 3,000 tickets are unallocated. So if you want to attend book one NOW!

Video: John Dawson of Alliance Pharma presents at UK Investor Show

Published 457 days ago

Alliance Pharma (APH) has, relatively, recently completed a transformational acquisition. I know that Nigel Wray remains a big fan as does Mark Slater. Sensible value investors should thus find the presentation by John Dawson of interest

This Small Pharma is Expanding into the US and Asia- A Wise Move if We Quit Europe.

Published 532 days ago

Hello Share Trekkies. The health game is a good place to be for winning share seekers like us in 2016. Bio-science firms are set to reap the benefit of an ageing world population with all its attendant health problems. And even younger folk will sadly require more medical care, unless they can do something about their unhealthy diets.

Tom Winnifrith Bearcast 26 November - taking more lectures from Hanoi Jane Paul Scott

Published 632 days ago

Oh no Paul Scott is giving me health advice again. If he promises never ever to waterboard me again with online retail gross margins I might just quit smoking. Away from that I look at car crash Slater & Gordon (SGH) following up from the earlier detailed piece HERE. In a similar vein I look at NAHL (NAH). Then it is onto EKF Diagnostics (EKF), Moneyswap (SWAP), Oilex (OEX), Forte Energy (FTE), Alliance Pharma (APH), Iofina (IOF) and the Fitbug (FITB) dog. There is no mention of Jabba The Hutt today, David Lenigas must wait for Gold & Bears on Saturday for his next drubbing. And boy will it be a drubbing.

Buy Petropavlovsk at 6.47p - target price to sell within 3 years 19p

Published 671 days ago

Investment Case: As noted last month with Berkeley Energy, it is not a surprise to see eye-watering share price declines over previous years for stocks with sector: “Mining”. Shares in *Petropavlovsk plc, formerly Peter Hambro Mining, (POG) have particularly suffered – they down from more than 400p at the commencement of 2011 and more than 100p at the commencement of 2013 to a current 6.47p offer price – amidst a combination of sector-wide and company-specific challenges, the latter including a vast debt pile. However, a recent refinancing and refocusing – with production now being optimised from a cash generation point of view – now offer the promise of a decent recovery from current levels and the shares are a buy…the target price to sell is 19p within three years.

Alliance Pharma - bank gains & sell

Published 811 days ago

Alliance Pharma (APH) has updated investors that “trading in the first four months of 2015 has been satisfactory” and that“we look forward to the remainder of 2015 with confidence.”

Video of the healthcare and biotech masterclass at Uk Investor 2015

Published 833 days ago

Amiong those presenting in the healthcare and biotech master class were John Dawson of Alliance Pharma, Steve Moore, Adam Reynolds of Premaitha and Optibiotix, Venn Life and Collagen. Enjoy

Hear Nigel Wray (and TW) fave Alliance Pharma this Thursday (23rd) and get free food

Published 851 days ago

Alliance Pharma (APH) is a stock that Britain’s Buffett had held for ten years and it is also a great sleep-sound core portfolio buy for me.  Its CEO John Dawson is a good man and I like the company. Anyhow he, and the CEOs of Rex Bionics, Accesso and Akers Biosciences, of which I know sweet FA are presenting in London at the Proactive forum this Thursday 23rd). There’s free food & booze on offer as well. And

Alliance Pharma 2014 results okay, 2015 will be better: Buy!

Published 876 days ago

Speciality pharmaceuticals company Alliance Pharma (APH) has announced results for the 2014 calendar year and that “we enter 2015 well placed for resumed growth”. That is not discounted in the current share price.

Alliance Pharma Trading Update – all on track

Published 942 days ago

Speciality pharmaceutical company, Alliance Pharma (APH) has updated that 2014 “pre-tax profits are expected to be in line with current market expectations” on turnover of £43.5 million and that “we continue to evaluate a number of acquisition opportunities”

Alliance Pharma Interims - buy at up to 35p

Published 1070 days ago

Alliance Pharma (APH) last week announced results for the first half of the 2014 calendar year and that “we expect full year results to be in line with market expectations”.  This makes the shares a buy at up to 35p

Alliance Pharma AGM - Good News

Published 1183 days ago

Alliance Pharma (APH) has updated investors attending its AGM that “trading in the first four months of 2014 has been in line with expectations” and that “we continue to work towards delivering further earnings enhancing acquisitions to outperform those plans”

Alliance Pharma - AGM trading update, still the right prescription?

Published 1548 days ago

AIM-listed speciality pharmaceutical company Alliance Pharma (APH) has updated that “trading in the first four months of 2013 has been 6% ahead of the same period last year (5% on an underlying basis), with turnover of £15.1 million”.

Alliance Pharma - a rare AIM stock with the right prescription?

Published 1583 days ago

A new stock, of which star fund manager Mark Slater is a fan, has just been added to the Growth Portfolio on the 'Nifty Fifty' website which I write with Tom Winnifrith.

Free share tip of the week: Buy Alliance Pharma at 36.5p

Published 1590 days ago

Alliance Pharma (APH), the speciality pharmaceutical company which acquires and licenses established products in niche areas, announced its calendar 2012 results a couple of weeks ago. The numbers contained no nasty shocks. That is no surprise, one of the great attractions of Alliance is that there is a real visibility of revenues. I tipped the shares on my premium Nifty Fifty service at 31p (offer price) in December and they now trade at 36-37p but are still a buy.


About ShareProphetsTerms of ServiceForgot My Password
Contact UsPrivacy PolicyForgot My Username
Advertise With UsCookie PolicyResend Account Validation Token
Send Us A Tip

Data by ADVFN / Site by Everywhen /